Hematology, Transfusion and Cell Therapy is a peer-reviewed english-language open-access journal published by Elsevier in Spain, operating under an open-access model since 2018. The journal covers Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs.
Authors publish in Hematology, Transfusion and Cell Therapy without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
All submissions undergo plagiarism screening before peer review.
Keywords
case reports, hematology, transfusion, hemotherapy
At a glance
- Publisher
- Elsevier
- Country
- Spain
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Double anonymous peer review
- OA since
- 2018
- Review time
- 30 weeks
- Plagiarism check
- Yes
ISSN
- 2531-1379
- electronic
- 2531-1387
Frequently asked questions
Is Hematology, Transfusion and Cell Therapy peer-reviewed?
Does Hematology, Transfusion and Cell Therapy charge an article processing charge (APC)?
What subjects does Hematology, Transfusion and Cell Therapy publish?
What languages does Hematology, Transfusion and Cell Therapy accept?
What is the ISSN of Hematology, Transfusion and Cell Therapy?
2531-1379 (print) · 2531-1387 (electronic).